These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26719704)

  • 1. Epidermal growth factor, latrophilin, and seven transmembrane domain-containing protein 1 marker, a novel angiogenesis marker.
    Serban F; Artene SA; Georgescu AM; Purcaru SO; Tache DE; Alexandru O; Dricu A
    Onco Targets Ther; 2015; 8():3767-74. PubMed ID: 26719704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ELTD1 as a multi-focal target for malignant gliomas: preclinical studies.
    Zalles M; Smith N; Saunders D; Guzman M; Lerner M; Fung KM; Babu A; Battiste J; Chung J; Hwang K; Jin J; Towner RA
    Neurooncol Adv; 2021; 3(1):vdab132. PubMed ID: 34704036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADGRL4/ELTD1 is a highly conserved angiogenesis-associated orphan adhesion GPCR that emerged with the first vertebrates and comprises 3 evolutionary variants.
    Favara DM; Banham AH; Harris AL
    BMC Evol Biol; 2019 Jul; 19(1):143. PubMed ID: 31299890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADGRL4/ELTD1 Silencing in Endothelial Cells Induces ACLY and SLC25A1 and Alters the Cellular Metabolic Profile.
    Favara DM; Zois CE; Haider S; Pires E; Sheldon H; McCullagh J; Banham AH; Harris AL
    Metabolites; 2019 Nov; 9(12):. PubMed ID: 31775252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ELTD1 is present in extracellular vesicles derived from endothelial cells as a cleaved extracellular domain which induces in vivo angiogenesis.
    Sheldon H; Zhang W; Bridges E; Ang KH; Lin S; Masiero M; Li D; Handford PA; Whiteman P; Fischer R; Buffa F; Vatish M; Banham AH; Harris AL
    J Extracell Biol; 2022 Aug; 1(8):e52. PubMed ID: 38939053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New life for an old therapy: ELTD1 as a downstream target of angiogenesis.
    Tiek DM; Cheng SY
    Neuro Oncol; 2022 Mar; 24(3):412-413. PubMed ID: 35015881
    [No Abstract]   [Full Text] [Related]  

  • 7. ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma models.
    Ziegler J; Pody R; Coutinho de Souza P; Evans B; Saunders D; Smith N; Mallory S; Njoku C; Dong Y; Chen H; Dong J; Lerner M; Mian O; Tummala S; Battiste J; Fung KM; Wren JD; Towner RA
    Neuro Oncol; 2017 Feb; 19(2):175-185. PubMed ID: 27416955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of epidermal growth factor, latrophilin and seven transmembrane domain-containing protein 1 (ELTD1) via siRNA-induced cell death in glioblastoma.
    Serban F; Daianu O; Tataranu LG; Artene SA; Emami G; Georgescu AM; Alexandru O; Purcaru SO; Tache DE; Danciulescu MM; Sfredel V; Dricu A
    J Immunoassay Immunochem; 2017; 38(1):21-33. PubMed ID: 27379831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ELTD1 Review: New Regulator of Angiogenesis in Glioma.
    Buzatu I; Tache DE; Manea Carneluti EV; Zlatian O
    Curr Health Sci J; 2023; 49(4):495-502. PubMed ID: 38559823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Overview of Systemic Targeted Therapy in Renal Cell Carcinoma, with a Focus on Metastatic Renal Cell Carcinoma and Brain Metastases.
    Semenescu LE; Kamel A; Ciubotaru V; Baez-Rodriguez SM; Furtos M; Costachi A; Dricu A; Tătăranu LG
    Curr Issues Mol Biol; 2023 Sep; 45(9):7680-7704. PubMed ID: 37754269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Overview of EGFR Mechanisms and Their Implications in Targeted Therapies for Glioblastoma.
    Rodriguez SMB; Kamel A; Ciubotaru GV; Onose G; Sevastre AS; Sfredel V; Danoiu S; Dricu A; Tataranu LG
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frozen bean curd-inspired xenogeneic acellular dermal matrix with triple pretreatment approach of freeze-thaw, laser drilling and ADSCs pre-culture for promoting early vascularization and integration.
    Huang X; Zhu Z; Lu L; Jin R; Sun D; Luo X
    Regen Biomater; 2022; 9():rbac053. PubMed ID: 35974951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic Signalling of Growth Factor Receptors in Cancer: Mechanisms and Therapeutic Opportunities.
    Dricu A
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioblastoma Stem Cells-Useful Tools in the Battle against Cancer.
    Rodriguez SMB; Staicu GA; Sevastre AS; Baloi C; Ciubotaru V; Dricu A; Tataranu LG
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ELTD1 Promotes Gastric Cancer Cell Proliferation, Invasion and Epithelial-Mesenchymal Transition Through MAPK/ERK Signaling by Regulating CSK.
    Sun B; Zhong FJ
    Int J Gen Med; 2021; 14():4897-4911. PubMed ID: 34475781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ELTD1 promotes invasion and metastasis by activating MMP2 in colorectal cancer.
    Sun J; Zhang Z; Chen J; Xue M; Pan X
    Int J Biol Sci; 2021; 17(12):3048-3058. PubMed ID: 34421349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADGRL4/ELTD1 Expression in Breast Cancer Cells Induces Vascular Normalization and Immune Suppression.
    Sheldon H; Bridges E; Silva I; Masiero M; Favara DM; Wang D; Leek R; Snell C; Roxanis I; Kreuzer M; Gileadi U; Buffa FM; Banham A; Harris AL
    Mol Cancer Res; 2021 Nov; 19(11):1957-1969. PubMed ID: 34348993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ELTD1-An Emerging Silent Actor in Cancer Drama Play.
    Sevastre AS; Buzatu IM; Baloi C; Oprita A; Dragoi A; Tataranu LG; Alexandru O; Tudorache S; Dricu A
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068040
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.